{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:14:27Z","timestamp":1777878867717,"version":"3.51.4"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2022.0327"],"award-info":[{"award-number":["KAW 2022.0327"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2021.0141"],"award-info":[{"award-number":["KAW 2021.0141"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022\\u201301,661"],"award-info":[{"award-number":["2022\\u201301,661"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","award":["44,135"],"award-info":[{"award-number":["44,135"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003185","name":"Fraunhofer-Gesellschaft Headquarters","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE032712"],"award-info":[{"award-number":["R01DE032712"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["708,096"],"award-info":[{"award-number":["708,096"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["461,274"],"award-info":[{"award-number":["461,274"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["461,275"],"award-info":[{"award-number":["461,275"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["193,741"],"award-info":[{"award-number":["193,741"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["407,016"],"award-info":[{"award-number":["407,016"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["155,924"],"award-info":[{"award-number":["155,924"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1682\/16"],"award-info":[{"award-number":["1682\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003483","name":"Hebrew University of Jerusalem","doi-asserted-by":"publisher","award":["3175,000,798"],"award-info":[{"award-number":["3175,000,798"]}],"id":[{"id":"10.13039\/501100003483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2019\\u201306,824"],"award-info":[{"award-number":["RGPIN-2019\\u201306,824"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejps.2025.107388","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:52:38Z","timestamp":1764291158000},"page":"107388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nortriptyline-targeted siRNA-loaded liposomes: Design, affinity, biodistribution, and bioactivity in a murine Herpes Simplex Virus 1 corneal infection model"],"prefix":"10.1016","volume":"217","author":[{"given":"Doaa","family":"Jbara-Agbaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neethi C","family":"Thathapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Groleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majd","family":"Agbaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Callai","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Laganiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-9831","authenticated-orcid":false,"given":"Gershon","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107388_bib0001","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107388_bib0002","first-page":"1482","article-title":"Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: formulation, biodistribution and bioactivity in mice","author":"Agbaria","year":"2025","journal-title":"Precis. Nanomed."},{"key":"10.1016\/j.ejps.2025.107388_bib0003","article-title":"Targeting siRNA nanoparticles with ApoB peptide: formulation, biodistribution, and bioactivity in pancreatic tumor-bearing mice","volume":"108","author":"Agbaria","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2025.107388_bib0004","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13346-017-0435-y","article-title":"Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases","volume":"8","author":"Agrahari","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0005","series-title":"Herpes Simplex encephalitis, Statpearls","author":"Ak","year":"2025"},{"key":"10.1016\/j.ejps.2025.107388_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev. Biomed. Eng."},{"key":"10.1016\/j.ejps.2025.107388_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020206","article-title":"Lipid nanoparticles as delivery systems for RNA-based vaccines","volume":"13","author":"Aldosari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107388_bib0008","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1038\/s41598-018-24860-8","article-title":"Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells","volume":"8","author":"Alshehri","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107388_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00006-24","article-title":"The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis","volume":"37","author":"Antony","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0010","first-page":"614","article-title":"An SV40-immortalized human corneal epithelial cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2025.107388_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00794-20","article-title":"Human corneal epithelial cells internalize aspergillus flavus spores by actin-mediated endocytosis","volume":"89","author":"Arunachalam","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejps.2025.107388_bib0012","doi-asserted-by":"crossref","DOI":"10.3791\/52065-v","article-title":"Viral concentration determination through plaque assays: using traditional and novel overlay systems","author":"Baer","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2025.107388_bib0013","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/pharmaceutics11080360","article-title":"Lipid delivery systems for nucleic-acid-based-drugs: from production to clinical applications","volume":"11","author":"Barba","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107388_bib0014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2008.12.010","article-title":"Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells","volume":"36","author":"Bayer","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2025.107388_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/cancers11040442","article-title":"Targeted siRNA nanoparticles for mammary carcinoma therapy","volume":"11","author":"Ben-David-Naim","year":"2019","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2025.107388_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174465","article-title":"Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: comparison with adult rats","volume":"910","author":"Bis-Humbert","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0017","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11064-017-2217-9","article-title":"5-HT6 receptor agonist and antagonist against beta-amyloid-peptide-induced neurotoxicity in PC-12 cells","volume":"42","author":"Bokare","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0018","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biomaterials.2006.09.026","article-title":"Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films","volume":"28","author":"Brunot","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2025.107388_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11940-019-0557-2","article-title":"Antidepressants for preventive treatment of migraine","volume":"21","author":"Burch","year":"2019","journal-title":"Curr. Treat. Options. Neurol."},{"key":"10.1016\/j.ejps.2025.107388_bib0020","article-title":"Incidence and risk factors of bilateral herpetic keratitis: 2022 update","volume":"7","author":"Chaloulis","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107388_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1542\/pir.30.4.119","article-title":"Herpes simplex","volume":"30","author":"Chayavichitsilp","year":"2009","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1039\/C0CS00003E","article-title":"Strategies for the intracellular delivery of nanoparticles","volume":"40","author":"Chou","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0023","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2025.107388_bib0024","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.addr.2012.08.014","article-title":"RNAi-based nanomedicines for targeted personalized therapy","volume":"64","author":"Daka","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124192","article-title":"Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics","volume":"658","author":"Datta","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107388_bib0026","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s13346-016-0299-6","article-title":"Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration","volume":"6","author":"Du","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0027","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fphar.2018.00971","article-title":"Non-viral delivery of nucleic acids: insight into mechanisms of overcoming intracellular barriers","volume":"9","author":"Durymanov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0028","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107388_bib0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12248-008-9060-5","article-title":"Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization","volume":"10","author":"Epstein","year":"2008","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2025.107388_bib0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1874192400802010060","article-title":"Predicting in vivo efficacy of potential restenosis therapies by cell culture studies: species-dependent susceptibility of vascular smooth muscle cells","volume":"2","author":"Epstein","year":"2008","journal-title":"Open. Cardiovasc. Med. J."},{"key":"10.1016\/j.ejps.2025.107388_bib0031","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107388_bib0032","series-title":"Current Advances in Optometry","first-page":"115","article-title":"Novel ocular drug delivery methods","author":"Fang","year":"2024"},{"key":"10.1016\/j.ejps.2025.107388_bib0033","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107388_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177441","article-title":"siRNA-based delivery systems: technologies, carriers, applications, and approved products","volume":"996","author":"Ghasemiyeh","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/v15010225","article-title":"A comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis","volume":"15","author":"Gopinath","year":"2023","journal-title":"Viruses."},{"key":"10.1016\/j.ejps.2025.107388_bib0037","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC. Adv."},{"key":"10.1016\/j.ejps.2025.107388_bib0038","unstructured":"Griffith, M., Zamani-Roudbaraki, M., Boutopoulos, C., Latorre, M., Robert, M.-C., Farahani, M., Hedayatnia, A., Savoji, H., 2024. MPC-based copolymers and hydrogels, and uses thereof in regenerative medicine. World intellectual property organization; intl. Publ. #WO2024\/254694 A1."},{"key":"10.1016\/j.ejps.2025.107388_bib0039","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bph.12330","article-title":"Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy","volume":"170","author":"Guzman-Aranguez","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114396","article-title":"A brief history of long circulating nanoparticles","volume":"188","author":"Haroon","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.11607\/jop.1154","article-title":"Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment","volume":"28","author":"Haviv","year":"2014","journal-title":"J. Oral Facial. Pain. Headache"},{"key":"10.1016\/j.ejps.2025.107388_bib0042","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2025.107388_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21688370.2018.1502531","article-title":"Roles of membrane lipids in the organization of epithelial cells: old and new problems","volume":"6","author":"Ikenouchi","year":"2018","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejps.2025.107388_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030633","article-title":"Liposomal siRNA formulations for the treatment of Herpes Simplex Virus-1: in vitro characterization of physicochemical properties and activity, and in vivo biodistribution and toxicity studies","volume":"14","author":"Jbara-Agbaria","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107388_bib0045","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418810583","article-title":"Neuroprotective effect of nortriptyline in overt hepatic encephalopathy through attenuation of mitochondrial dysfunction","volume":"10","author":"Jeong","year":"2018","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ejps.2025.107388_bib0046","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1600-0854.2002.30701.x","article-title":"Clathrin-dependent or not: is it still the question?","volume":"3","author":"Johannes","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.ejps.2025.107388_bib0047","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s13346-018-0504-x","article-title":"A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery","volume":"8","author":"Kabiri","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010688","article-title":"Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells","volume":"18","author":"Kalke","year":"2022","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.ejps.2025.107388_bib0049","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/17425247.2011.554818","article-title":"Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems","volume":"8","author":"Karmali","year":"2011","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107388_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/2589977514666220913120718","article-title":"Nanocarriers based ocular therapeutics: updates, challenges and future prospectives","volume":"15","author":"Kaushal","year":"2023","journal-title":"Curr. Drug Res. Rev."},{"key":"10.1016\/j.ejps.2025.107388_bib0051","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.preteyeres.2006.05.001","article-title":"Herpes simplex keratitis","volume":"25","author":"Kaye","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0052","article-title":"Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders","author":"Khan","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0053","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3949\/ccjm.73.4.351","article-title":"Side effects of antidepressants: an overview","volume":"73","author":"Khawam","year":"2006","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejps.2025.107388_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903637","article-title":"Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery","volume":"31","author":"Kim","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejps.2025.107388_bib0055","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.2174\/0929867325666180309105519","article-title":"Acyclovir in the treatment of herpes viruses - a review","volume":"27","author":"Klysik","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107388_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7100429","article-title":"Current and emerging therapies for ocular Herpes Simplex Virus type-1 infections","volume":"7","author":"Koganti","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejps.2025.107388_bib0057","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-018-2938-1","article-title":"Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea","volume":"76","author":"Koujah","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejps.2025.107388_bib0058","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/1566524014666141021145909","article-title":"A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis","volume":"14","author":"Li","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejps.2025.107388_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100417","article-title":"Dissection of the relationship between anxiety and stereotyped self-grooming using the Shank3B mutant autistic model, acute stress model and chronic pain model","volume":"15","author":"Liu","year":"2021","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.ejps.2025.107388_bib0060","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107388_bib0061","article-title":"Development of mRNA lipid nanoparticles: targeting and therapeutic aspects","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107388_bib0062","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0420.1995.tb00008.x","article-title":"Recurrence and rejection rates following corneal transplantation for herpes simplex keratitis","volume":"73","author":"Lomholt","year":"1995","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ejps.2025.107388_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20220045","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.ejps.2025.107388_bib0064","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/IJN.S121450","article-title":"Comparison of the cellular transport mechanism of cationic, star-shaped polymers and liposomes in hacat cells","volume":"12","author":"Luo","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2025.107388_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118022","article-title":"Anti-herpes virus strategies of nanomaterials: research progress on direct inhibition mechanisms and targeted delivery systems","volume":"298","author":"Ma","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107388_bib0067","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s13337-018-00508-z","article-title":"siRNA intervention inhibiting viral replication and delivery strategies for treating herpes simplex viral infection","volume":"30","author":"Manda","year":"2019","journal-title":"Virusdisease"},{"key":"10.1016\/j.ejps.2025.107388_bib0068","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-020-02161-7","article-title":"Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators","volume":"127","author":"Messlinger","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejps.2025.107388_bib0069","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1177\/0333102418786261","article-title":"Current understanding of trigeminal ganglion structure and function in headache","volume":"39","author":"Messlinger","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejps.2025.107388_bib0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0041-008X(66)90039-1","article-title":"Toxicology of nortriptyline hydrochloride","volume":"9","author":"Meyers","year":"1966","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0071","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010611-134623","article-title":"Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective","volume":"52","author":"Moghimi","year":"2012","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0072","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v13.i1.89934","article-title":"Herpes simplex keratitis: a brief clinical overview","volume":"13","author":"Musa","year":"2024","journal-title":"World J. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0073","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1128\/JVI.02207-10","article-title":"Herpes Simplex Virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation","volume":"85","author":"Nagel","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0074","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2025.107388_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijch.201300055","article-title":"Gene delivery by liposomes","volume":"53","author":"Nordling-David","year":"2013","journal-title":"Isr. J. Chem."},{"key":"10.1016\/j.ejps.2025.107388_bib0076","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2018028431","article-title":"Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD","volume":"3","author":"Ohigashi","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejps.2025.107388_bib0077","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/jmv.24578","article-title":"Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools","volume":"88","author":"Paavilainen","year":"2016","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0078","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3851\/IMP3153","article-title":"Topical treatment of herpes simplex virus infection with enzymatically created siRNA swarm","volume":"22","author":"Paavilainen","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejps.2025.107388_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010001","article-title":"Advancement on sustained antiviral ocular drug delivery for Herpes Simplex Virus keratitis: recent update on potential investigation","volume":"13","author":"Pandey","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107388_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.ejps.2025.107388_bib0081","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acs.bioconjchem.8b00778","article-title":"Overcoming endosomal entrapment in drug delivery","volume":"30","author":"Pei","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2025.107388_bib0082","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107388_bib0083","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0039-6257(05)80068-2","article-title":"Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line","volume":"39","author":"Pleyer","year":"1995","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107388_bib0084","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01586-19","article-title":"Herpes Simplex Virus 1 replication, ocular disease, and reactivations from latency are restricted unilaterally after inoculation of virus into the lip","volume":"93","author":"Poccardi","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0005-2736(01)00330-3","article-title":"Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma","volume":"1512","author":"Price","year":"2001","journal-title":"Bba-Biomembranes"},{"key":"10.1016\/j.ejps.2025.107388_bib0086","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1002\/rmv.1976","article-title":"A review on current status of antiviral siRNA","volume":"28","author":"Qureshi","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0087","article-title":"Advancing ocular medication delivery with nano-engineered solutions: a comprehensive review of innovations, obstacles, and clinical impact","volume":"16","author":"Rajan","year":"2024","journal-title":"Cureus."},{"key":"10.1016\/j.ejps.2025.107388_bib0088","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2025.107388_bib0089","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1086\/648474","article-title":"Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck","volume":"200","author":"Richter","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107388_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198015","article-title":"The HSV-1 ubiquitin ligase ICP0: modifying the cellular proteome to promote infection","volume":"285","author":"Rodr\u00edguez","year":"2020","journal-title":"Virus. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0091","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s13346-016-0335-6","article-title":"Ocular drug delivery\u2014Eye on innovation","volume":"6","author":"Rupenthal","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0092","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01314229","article-title":"Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse","volume":"85","author":"Shimeld","year":"1985","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0093","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.tiv.2008.07.001","article-title":"Influence of cytotoxic doses of 4-hydroxynonenal on selected neurotransmitter receptors in PC-12 cells","volume":"22","author":"Siddiqui","year":"2008","journal-title":"Toxicol. In. Vitro"},{"key":"10.1016\/j.ejps.2025.107388_bib0094","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.actbio.2017.01.057","article-title":"Cellular interactions of a lipid-based nanocarrier model with human keratinocytes: unravelling transport mechanisms","volume":"53","author":"Silva","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2025.107388_bib0095","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2494775","article-title":"PEGylation technology: addressing concerns, moving forward","volume":"32","author":"Simberg","year":"2025","journal-title":"Drug Deliv."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2025.107388_bib0096","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/342967","article-title":"Clinical manifestations and treatment considerations of herpes simplex virus infection","volume":"186","author":"Simmons","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107388_bib0097","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41536-024-00355-1","article-title":"Inflammation-suppressing cornea-in-a-syringe with anti-viral GF19 peptide promotes regeneration in HSV-1 infected rabbit corneas","volume":"9","author":"Simoliunas","year":"2024","journal-title":"NPJ. Regen. Med."},{"key":"10.1016\/j.ejps.2025.107388_bib0098","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s42003-021-02108-y","article-title":"Collagen analogs with phosphorylcholine are inflammation-suppressing scaffolds for corneal regeneration from alkali burns in mini-pigs","volume":"4","author":"Simpson","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejps.2025.107388_bib0099","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/fvl.11.24","article-title":"HSV-1 ICP0: paving the way for viral replication","volume":"6","author":"Smith","year":"2011","journal-title":"Future Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/JVI.80.1.218-225.2006","article-title":"ICP0 prevents RNase l-independent rRNA cleavage in herpes simplex virus type 1-infected cells","volume":"80","author":"Sobol","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2025.107388_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41881","article-title":"Drug delivery strategies to improve the treatment of corneal disorders","volume":"11","author":"Tafti","year":"2025","journal-title":"Heliyon."},{"key":"10.1016\/j.ejps.2025.107388_bib0102","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10717544.2015.1092183","article-title":"Lipid-based nanocarriers for breast cancer treatment \u2013 comprehensive review","volume":"23","author":"Talluri","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107388_bib0103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107388_bib0104","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS. Nano"},{"key":"10.1016\/j.ejps.2025.107388_bib0105","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0002-9440(10)63575-4","article-title":"Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response","volume":"163","author":"Theil","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2025.107388_bib0106","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ICU.0000000000000618","article-title":"Ocular manifestations of herpes simplex virus","volume":"30","author":"Valerio","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107388_bib0107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","article-title":"Targeted nanomedicine: lessons learned and future directions","volume":"355","author":"Veiga","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107388_bib0108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10717544.2014.913325","article-title":"Potential of targeted drug delivery system for the treatment of bone metastasis","volume":"23","author":"Vinay","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107388_bib0109","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107388_bib0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.virusres.2013.01.001","article-title":"HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice","volume":"173","author":"Wang","year":"2013","journal-title":"Virus. Res."},{"key":"10.1016\/j.ejps.2025.107388_bib0111","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","article-title":"Delivery of siRNA therapeutics: barriers and carriers","volume":"12","author":"Wang","year":"2010","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2025.107388_bib0112","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2174\/1566523220666201005110726","article-title":"Delivery systems for RNA interference therapy: current technologies and limitations","volume":"20","author":"Wang","year":"2020","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejps.2025.107388_bib0113","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/612316","article-title":"Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases","volume":"2012","author":"Webre","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejps.2025.107388_bib0114","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2025.107388_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2025.107388_bib0116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2011.09.093","article-title":"Uptake mechanisms of non-viral gene delivery","volume":"158","author":"Xiang","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107388_bib0117","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/DDDT.S96730","article-title":"Establishment of a novel therapeutic vector targeting the trigeminal ganglion in rats","volume":"10","author":"Xu","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2025.107388_bib0118","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2025.107388_bib0119","doi-asserted-by":"crossref","DOI":"10.1038\/srep21881","article-title":"Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis","volume":"6","author":"Yu-Wai-Man","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107388_bib0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jbm.a.35201","article-title":"Anti-inflammatory and protective effects of 2-methacryloyloxyethyl phosphorylcholine polymer on oral epithelial cells","volume":"103","author":"Yumoto","year":"2015","journal-title":"J. Biomed. Mater. Res. a"},{"key":"10.1016\/j.ejps.2025.107388_bib0121","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1080\/10717544.2021.1995081","article-title":"Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors","volume":"28","author":"Zeng","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107388_bib0122","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2025.107388_bib0123","first-page":"56","article-title":"Inhibition of herpes simplex virus type 1 by small interfering RNA","volume":"33","author":"Zhang","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejps.2025.107388_bib0124","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:29:29Z","timestamp":1777591769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":123,"alternative-id":["S0928098725003859"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107388","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nortriptyline-targeted siRNA-loaded liposomes: Design, affinity, biodistribution, and bioactivity in a murine Herpes Simplex Virus 1 corneal infection model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107388"}}